Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (PDF, 156KB)
Why become a member?

Open Medicine Foundation Commits $1.2M To Fund ME/CFS Research

Thursday 7 December 2017

 

From GenomeWeb:

 

Dr Ron Davis
Dr Ron Davis, leader of The ME/CFS
Collaborative Research Center at Stanford.
 

Open Medicine Foundation Commits $1.2M to Fund ME/CFS Research

By staff reporter
December 5, 2017
Copyright © 2017 GenomeWeb LLC. All Rights Reserved.

NEW YORK (GenomeWeb) – The Open Medicine Foundation (OMF) announced today that it has committed $1.2 million to fund the first year of operations at the newly established ME/CFS Collaborative Research Center at Stanford University.

According to the OMF, the center is focused on investigating the molecular basis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), as well as developing new diagnostics and treatments for the conditions. Its initial projects involve sequencing single T cells to understand the immunological basis of ME/CFS; analyzing sets of genomic and other omics data to define patient subgroups, uncover disease biomarkers, and identify potential drug targets; and developing a blood-based ME/CFS diagnostic that can also be used as a reporter in drug screening.

 

Full article…

 


 

blog comments powered by Disqus

Previous Previous Page